» Articles » PMID: 9431821

Arachidonylethanolamide (anandamide) Binds with Low Affinity to Dihydropyridine Binding Sites in Brain Membranes

Overview
Specialty Endocrinology
Date 1998 Feb 7
PMID 9431821
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to explore the hypothesis that the dihydropyridine (DHP) binding site of the L-type calcium channel is a high affinity binding site for the cannabimimetic arachidonylethanolamide (AEA). Binding affinities were determined from competition isotherms using the DHP analog [3H]PN-200. AEA competed for [3H]PN-200 binding with a K(I) of 40 +/- 4 microM. Inclusion of phenylmethylsulfonyl fluoride to inhibit an amidohydrolase that converts AEA to arachidonic acid had little effect on the K(I) of AEA (48 +/- 6 microM). Arachidonic acid had a slightly higher K(I) (120 +/- 11 microM) and other N-acylethanolamides examined (linolenylethanolamide, dihomo-gamma-linolenylethanolamide, docosatetraenylethanolamide, and palmitoylethanolamide) had no effect on [3H]PN-200 binding at concentrations as high as 10 microM. Our conclusions are that AEA binds to the DHP binding site with relatively low affinity and its conversion to arachidonic acid is not required for binding.

Citing Articles

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.

Pertwee R, Howlett A, Abood M, Alexander S, Di Marzo V, Elphick M Pharmacol Rev. 2010; 62(4):588-631.

PMID: 21079038 PMC: 2993256. DOI: 10.1124/pr.110.003004.


Regulation of voltage-gated Ca2+ channels by lipids.

Roberts-Crowley M, Mitra-Ganguli T, Liu L, Rittenhouse A Cell Calcium. 2009; 45(6):589-601.

PMID: 19419761 PMC: 2964877. DOI: 10.1016/j.ceca.2009.03.015.


Arachidonic acid inhibition of L-type calcium (CaV1.3b) channels varies with accessory CaVbeta subunits.

Roberts-Crowley M, Rittenhouse A J Gen Physiol. 2009; 133(4):387-403.

PMID: 19332620 PMC: 2699108. DOI: 10.1085/jgp.200810047.


Effects of chronic nitric oxide synthase inhibition on the cardiovascular responses to cannabinoids in vivo and in vitro.

Wheal A, Bennett T, Randall M, Gardiner S Br J Pharmacol. 2007; 150(5):662-71.

PMID: 17245361 PMC: 2043496. DOI: 10.1038/sj.bjp.0707136.


Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts.

Ford W, Honan S, White R, Hiley C Br J Pharmacol. 2002; 135(5):1191-8.

PMID: 11877326 PMC: 1573229. DOI: 10.1038/sj.bjp.0704565.